skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Obesity, Fitness, & Wellness Week remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Studies from Massachusetts General Hospital Yield New Data on Gene Therapy (Death After High-dose Raav9 Gene Therapy In a Patient With Duchenne's Muscular Dystrophy)
Studies from Massachusetts General Hospital Yield New Data on Gene Therapy (Death After High-dose Raav9 Gene Therapy In a Patient With Duchenne's Muscular Dystrophy)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Studies from Massachusetts General Hospital Yield New Data on Gene Therapy (Death After High-dose Raav9 Gene Therapy In a Patient With Duchenne's Muscular Dystrophy)

Obesity, fitness, & wellness week, 2024-03, p.90

NewsRX LLC

Texto completo disponível

Citações Citado por
2
New Limb-Girdle Muscular Dystrophies Study Results Reported from Qazvin University of Medical Sciences (Clinical and Genetic Characteristics of Limb-girdle Muscular Dystrophy In Iranian Patients)
New Limb-Girdle Muscular Dystrophies Study Results Reported from Qazvin University of Medical Sciences (Clinical and Genetic Characteristics of Limb-girdle Muscular Dystrophy In Iranian Patients)
Material Type:
Artigo 		Adicionar ao Meu Espaço

New Limb-Girdle Muscular Dystrophies Study Results Reported from Qazvin University of Medical Sciences (Clinical and Genetic Characteristics of Limb-girdle Muscular Dystrophy In Iranian Patients)

Obesity, fitness, & wellness week, 2024-04, p.321

NewsRX LLC

Texto completo disponível

Citações Citado por
3
Data on Gene Therapy Described by Researchers at Washington University St. Louis [Delandistrogene Moxeparvovec Gene Therapy In Ambulatory Patients (Aged=4 To 8?years) With Duchenne Muscular Dystrophy: 1-year Interim Results From Study ...]
Data on Gene Therapy Described by Researchers at Washington University St. Louis [Delandistrogene Moxeparvovec Gene Therapy In Ambulatory Patients (Aged=4 To 8?years) With Duchenne Muscular Dystrophy: 1-year Interim Results From Study ...]
Material Type:
Artigo 		Adicionar ao Meu Espaço

Data on Gene Therapy Described by Researchers at Washington University St. Louis [Delandistrogene Moxeparvovec Gene Therapy In Ambulatory Patients (Aged=4 To 8?years) With Duchenne Muscular Dystrophy: 1-year Interim Results From Study ...]

Obesity, fitness, & wellness week, 2023-11, p.21

NewsRX LLC

Texto completo disponível

Citações Citado por
4
Reports from Seoul National University Advance Knowledge in Muscular Dystrophy (Broad Spectrum of Phenotype and Genotype In Korean Alpha-dystroglycan Related Muscular Dystrophy Presenting To a Tertiary Pediatric Neuromuscular Center)
Reports from Seoul National University Advance Knowledge in Muscular Dystrophy (Broad Spectrum of Phenotype and Genotype In Korean Alpha-dystroglycan Related Muscular Dystrophy Presenting To a Tertiary Pediatric Neuromuscular Center)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Reports from Seoul National University Advance Knowledge in Muscular Dystrophy (Broad Spectrum of Phenotype and Genotype In Korean Alpha-dystroglycan Related Muscular Dystrophy Presenting To a Tertiary Pediatric Neuromuscular Center)

Obesity, fitness, & wellness week, 2023-06, p.366

NewsRX LLC

Texto completo disponível

Citações Citado por
5
Patent Issued for Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy (USPTO 11925675)
Patent Issued for Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy (USPTO 11925675)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Patent Issued for Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy (USPTO 11925675)

Obesity, fitness, & wellness week, 2024-04

NewsRX LLC

Texto completo disponível

Citações Citado por
6
CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2-deficiency in Merosin-deficient congenital muscular dystrophy
CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2-deficiency in Merosin-deficient congenital muscular dystrophy
Material Type:
Artigo 		Adicionar ao Meu Espaço

CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2-deficiency in Merosin-deficient congenital muscular dystrophy

Obesity, fitness, & wellness week, 2023-03, p.1261

NewsRX LLC

Texto completo disponível

Citações Citado por
7
Jeonbuk National University Medical School and Hospital Researchers Further Understanding of Becker Muscular Dystrophy
Jeonbuk National University Medical School and Hospital Researchers Further Understanding of Becker Muscular Dystrophy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Jeonbuk National University Medical School and Hospital Researchers Further Understanding of Becker Muscular Dystrophy

Obesity, fitness, & wellness week, 2023-02, p.2461

NewsRX LLC

Texto completo disponível

Citações Citado por
8
Study Data from Fulcrum Therapeutics Update Knowledge of Facioscapulohumeral Muscular Dystrophy [Safety and Efficacy of Losmapimod In Facioscapulohumeral Muscular Dystrophy (Redux4): a Randomised, Double-blind, Placebo-controlled Phase 2b Trial]
Study Data from Fulcrum Therapeutics Update Knowledge of Facioscapulohumeral Muscular Dystrophy [Safety and Efficacy of Losmapimod In Facioscapulohumeral Muscular Dystrophy (Redux4): a Randomised, Double-blind, Placebo-controlled Phase 2b Trial]
Material Type:
Artigo 		Adicionar ao Meu Espaço

Study Data from Fulcrum Therapeutics Update Knowledge of Facioscapulohumeral Muscular Dystrophy [Safety and Efficacy of Losmapimod In Facioscapulohumeral Muscular Dystrophy (Redux4): a Randomised, Double-blind, Placebo-controlled Phase 2b Trial]

Obesity, fitness, & wellness week, 2024-07, p.123

NewsRX LLC

Texto completo disponível

Citações Citado por
9
Reports on Pharmacogenomics from State University of New York
Reports on Pharmacogenomics from State University of New York
Material Type:
Artigo 		Adicionar ao Meu Espaço

Reports on Pharmacogenomics from State University of New York

Obesity, fitness, & wellness week, 2024-06, p.440

NewsRX LLC

Texto completo disponível

Citações Citado por
10
Reports on Pharmacogenomics from State University of New York (SUNY) Buffalo Provide New Insights (Assessing Pharmacogenomic iloci/i Associated With the Pharmacokinetics of Vamorolone In Boys With Duchenne Muscular Dystrophy)
Reports on Pharmacogenomics from State University of New York (SUNY) Buffalo Provide New Insights (Assessing Pharmacogenomic iloci/i Associated With the Pharmacokinetics of Vamorolone In Boys With Duchenne Muscular Dystrophy)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Reports on Pharmacogenomics from State University of New York (SUNY) Buffalo Provide New Insights (Assessing Pharmacogenomic iloci/i Associated With the Pharmacokinetics of Vamorolone In Boys With Duchenne Muscular Dystrophy)

Obesity, fitness, & wellness week, 2024-06, p.440

NewsRX LLC

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2010  (13)
  2. 2010Até2014  (24)
  3. 2015Até2017  (115)
  4. 2018Até2021  (209)
  5. Após 2021  (80)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.